Dr. Gerald Diaz @GeraldMD
23.4M 13.8K 7.2K
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief 🇵🇭 🇺🇸 - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG: https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Contributor Ranks
Latest Searches
16 results
idsa opportunistic prevention medications disorder drugs mycobacterium personality aviumcomplex candida candidiasis capsulatum cdiff clostridiumdifficile cmv cryptosporidiosis cytomegalovirus ebm effectiveness esophageal
Summary of meta-analysis of pharmacotherapy trials in BPD https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder Meta-analyses of RCTs were undertaken for the following outcomes:
with ‘treatment ... updated systematic review ... #Pharmacology # ... BPD #Borderline ... Effectiveness #Table
Drugs Used for the Treatment of COVID-19 Infection LOPINAVIR / RITONAVIR INTERFERON Beta-I REMDESIVIR HYDROXYCHLOROQUINE TOCILIZUMAB Piotr Okupski @PiotrOkupski - Original Infographic
Drugs Used for the Treatment ... of COVID-19 Infection ... #Medications #Treatment ... #COVID19 #Pharmacology ... #Table #Management
Drugs Used for the Treatment of COVID-19 Infection ** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
Drugs Used for the Treatment ... of COVID-19 Infection ... HCQ treatment would ... #COVID19 #Pharmacology ... #Table #Management
Summary of meta-analysis of psychological treatment trials in BPD https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder Meta-analyses of RCTs were undertaken for the following
Guideline for the Management ... updated systematic review ... summarised in Tables ... #Management #Psychological ... #Treatment #BPD
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS Preventing 1st Episode of Penicilliosis (Primary
itraconazolea 200 mg PO BID ... IDSA #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days) Preferred
chew, or crush tablet ... suspension 400 mg PO BID ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS Treating Isospora belli Infection General Management Considerations: • Fluid
General Management ... IDSA #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS Treating Orolabial Lesions (Duration: 5–10 days)
• Continue treatment ... IDSA #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS Preventing CMV Disease: • CMV end-organ disease is best
Cytomegalovirus Infections ... Valganciclovir 900 mg PO BID ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
Potential Treatment Agents for Treatment of the Primary Clostridium difficile infection Episode Proven efficacy: • Vancomycin -
Potential Treatment ... Agents for Treatment ... Clostridium difficile infection ... #management #pharmacology ... #idsa #table
empty